Patents by Inventor Deborah A. Paul

Deborah A. Paul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5830636
    Abstract: Monoclonal antibodies are described which specifically bind to Hepatitis E Virus (HEV), and more particularly to HEV orf-2 antigen. Also provided are hybridoma cell lines which secrete these monoclonal antibodies, methods for using these monoclonal antibodies, and assay kits which contain these monoclonal antibodies.
    Type: Grant
    Filed: February 22, 1996
    Date of Patent: November 3, 1998
    Assignee: Abbott Laboratories
    Inventors: Deborah A. Paul, Mark F. Knigge
  • Patent number: 5667966
    Abstract: Monoclonal antibodies are described which specifically bind to Hepatitis E Virus (HEV), and more particularly to HEV orf-3 antigen. Also provided are hybridoma cell lines which secrete these monoclonal antibodies, methods for using these monoclonal antibodies, and assay kits which contain these monoclonal antibodies.
    Type: Grant
    Filed: August 22, 1996
    Date of Patent: September 16, 1997
    Assignee: Abbott Laboratories
    Inventors: Deborah A. Paul, Mark F. Knigge
  • Patent number: 4748110
    Abstract: The invention is a diagnostic immunoassay which detects human T-cell lymphotropic virus-III (HTLV-III) antigen. The immunoassay utilizes a sandwich assay technique and the addition of a labeled second antibody to increase sensitivity. The second antibody is from an animal species different from the first.
    Type: Grant
    Filed: September 25, 1985
    Date of Patent: May 31, 1988
    Assignee: Abbott Laboratories
    Inventor: Deborah A. Paul